Alessandro M Gianni

Alessandro M Gianni

UNVERIFIED PROFILE

Are you Alessandro M Gianni?   Register this Author

Register author
Alessandro M Gianni

Alessandro M Gianni

Publications by authors named "Alessandro M Gianni"

Are you Alessandro M Gianni?   Register this Author

83Publications

1951Reads

15Profile Views

Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.

Am J Clin Oncol 2017 02;40(1):60-65

*Department of Medical Oncology †Clinical Epidemiology and Trials Organization Unit ‡Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori §Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COC.0000000000000113DOI Listing
February 2017

Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper.

Clin Lymphoma Myeloma Leuk 2015 Sep 19;15(9):507-13. Epub 2015 Jun 19.

University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.06.008DOI Listing
September 2015

YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.

Int J Cancer 2015 Jan 5;136(2):299-309. Epub 2014 Jun 5.

Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28993DOI Listing
January 2015

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Clin Cancer Res 2014 Nov 19;20(22):5641-51. Epub 2014 Sep 19.

Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Department of Pathophysiology and Transplantation, University of Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0770DOI Listing
November 2014

Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.

Clin Genitourin Cancer 2014 Jun 13;12(3):196-202.e1. Epub 2013 Nov 13.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.11.021DOI Listing
June 2014

Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.

PLoS One 2013 19;8(4):e61603. Epub 2013 Apr 19.

Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milano, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061603PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631141PMC
November 2013

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells.

Angiogenesis 2013 Jul 20;16(3):707-22. Epub 2013 Apr 20.

Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni, 56, 20089 Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10456-013-9348-7DOI Listing
July 2013

Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.

Clin Cancer Res 2012 Jun 2;18(12):3316-27. Epub 2012 May 2.

Human Tumors Immunobiology Unit, Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Medical Oncology Unit 3, Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426233PMC
June 2012

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.

Blood 2011 Oct 22;118(16):4421-30. Epub 2011 Aug 22.

C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-06-364570DOI Listing
October 2011

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

Cancer Res 2010 Nov 30;70(22):9062-72. Epub 2010 Sep 30.

C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Department of Experimental Oncology, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1825DOI Listing
November 2010

Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.

Am J Hematol 2010 Feb;85(2):147-55

Department of Oncology and Hematology, Hematology 2, Azienda Ospedaliera S. Giovanni Battista, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21602DOI Listing
February 2010

Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.

Oncologist 2009 ;14 Suppl 2:41-51

Hôpital Saint-Louis, Hémato-oncologie, 1 Avenue Claude Vellefaux, Paris 75010, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-S2-41DOI Listing
January 2010

A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments.

Lab Invest 2009 Sep 3;89(9):1063-70. Epub 2009 Aug 3.

Consiglio Nazionale delle Ricerche, Institute of Neuroscience, Cellular and Molecular Pharmacology Section, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.2009.76DOI Listing
September 2009

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

Blood 2009 Jan 22;113(1):18-27. Epub 2008 Sep 22.

C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Fondazione Istituti di ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-06-165654DOI Listing
January 2009

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

J Clin Oncol 2008 Nov 14;26(32):5175-82. Epub 2008 Oct 14.

Cristina Gandini Medical Oncology and Department of Nuclear Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.16.8294
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.16.8294DOI Listing
November 2008

Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells.

Adv Exp Med Biol 2008 ;610:100-11

University of Milano, Istituto Nazionale Tumori, Department of Medical Oncology, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-73898-7_8DOI Listing
July 2008

Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.

Eur J Cancer 2008 Mar 31;44(4):579-87. Epub 2008 Jan 31.

Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I-20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2007.12.016DOI Listing
March 2008

Targeting TRAIL agonistic receptors for cancer therapy.

Clin Cancer Res 2007 Apr;13(8):2313-7

Cristina Gandini Medical Oncology Unit, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-2774DOI Listing
April 2007

Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.

Blood 2006 Jan 8;107(2):602-9. Epub 2005 Sep 8.

Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-06-2234DOI Listing
January 2006

In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas.

Haematologica 2006 Jan;91(1):48-55

Oncogenic Fusion Protein Unit, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
January 2006

Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.

Eur J Cancer 2005 May 24;41(7):998-1006. Epub 2005 Feb 24.

Department of Medical Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2005.01.006DOI Listing
May 2005

Bone marrow transplantation for lymphoma CR1.

Curr Opin Oncol 2005 Mar;17(2):99-105

Department of Medicina-Oncologia Sp., Divisione Universitaria di Ematologia, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cco.0000152976.47551.d3DOI Listing
March 2005

Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.

Haematologica 2003 Dec;88(12):1396-404

C. Gandini Bone Marrow Transplantation Unit, Department of Medical Oncology, Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
December 2003

Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcome.

Anticancer Drugs 2002 Nov;13 Suppl 2:S35-42

Division of Medical Oncology and Bone Marrow Transplant, Milan Cancer Institute, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001813-200211002-00006DOI Listing
November 2002